4-traders (press release) We offer APIs, advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals . Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical ...
Wall Street Journal (press release) Mapi Pharma Ltd. (Mapi), developer of complex bulk Active Pharmaceutical Ingredients (APIs), generic and innovative intermediates , and finished dosage forms based on selected drug delivery systems, announced today that the company has been granted a ... 更多 »
PR Newswire (press release) The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals . Development and manufacturing capabilities include enzymatic biotransformations, high ... 更多 »
4-traders (press release) JiangSu AnDy is involved in research & development and production and sale of chemical intermediates for the pharmaceutical industry in China. Jiangsu AnDy's audited results for the 12 months ended 31 December 2012 showed profits before and after tax ...
Seeking Alpha Jiangchuan Macrolide product, JCM – TPI has completed its 240-ton JCM facility for the R&D, manufacturing and sale of API and chemical intermediates of macrolide antibiotics. Following the efficiency improvement and calibration for large scale ... 更多 »
EON: Enhanced Online News (press release) In addition to stability and release testing, Bend Research continues to offer analytical-method development and method validation for drug products and intermediates in a world-class Quality Control laboratory. The company recently added ... 更多 »
